Issue of Options

RNS Number : 8176R

Physiomics PLC

09 November 2011

 



Physiomics plc

(the "Company" or "Physiomics")

Issue of Options

The Company confirms that it has agreed to issue share options to each of its directors.

A total of 6,466,252 share options over ordinary shares in the Company ("Share Options") have now been granted to Mark Chadwick and Christophe Chassagnole under the Enterprise Management Initiative Scheme ("EMI"). The options are exercisable at a price of 0.34p each.

A total of 1,293,250 share options over ordinary shares in the Company ("Share Options") have now been granted to Paul Harper under an Unapproved share option scheme. The options are exercisable at a price of 0.34p each.

The options can be exercised within 10 years of the date of grant provided that satisfaction is achieved of certain pre-defined commercial conditions.

If all the new Share Options were to be exercised, they would represent 0.69% of the current issued share capital of the Company.

Following this issue, Mark Chadwick and Christophe Chassagnole will each hold 28,213,752 share options and Paul Harper will hold 11,285,501 share options over ordinary shares in the Company in accordance with the table below.

		Share Options
	Award no.	Granted	Exercise price	Expiry date
			p
Paul Harper	1	2,327,710	0.15	18-Dec-18
	2	7,664,541	0.40	28-Feb-20
	3	1,293,250	0.34	08-Nov-21
Christophe Chassagnole	1	7,499,453	0.383	06-Sep-17
	2	5,624,590	0.15	18-Dec-18
	3	11,856,584	0.40	28-Feb-20
	4	3,233,125	0.34	08-Nov-21
Mark Chadwick	1	24,980,625	0.27	05-Dec-20
	2	3,233,127	0.34	08-Nov-21

Enquiries:

Physiomics plc                                                  

Dr Mark Chadwick, CEO 

[phone]

WH Ireland Limited

Katy Mitchell

[phone]

 

END

 

 

RDSBLBFTMBAMBLB